Targeting PRC2 Enhances the Cytotoxic Capacity of Anti-CD19 CAR T Cells against Hematologic Malignancies

Journal:

Cancer Research

Published:

2025-06-15

DOI:

10.1158/0008-5472.can-24-1643

Affiliations:

12

Authors:

25

Go to article

Institutions	Authors	Share
A.C. Camargo Cancer Center (CIPE), Brazil	17.500000 17.500000	0.70
National Cancer Institute (INCA), Brazil	4.500000	0.18
Evandro Chagas Institute (IEC), Brazil	1.000000	0.04
Oswaldo Cruz Foundation (FIOCRUZ), Brazil	0.500000	0.02
National Institute of Science and Technology in Oncogenomics and Therapeutic Innovation (INCiTO-INOTE), Brazil	0.500000	0.02
Structural Genomics Consortium (SGC Toronto), Canada	0.333333	0.01
Princess Margaret Cancer Centre, U of T, Canada	0.333333	0.01
University of Toronto (U of T), Canada	0.333333	0.01

Interested in Oncology and Carcinogenesis?